Lixte Biotechnology Holdings Inc

#138 in public LIXT.US public

Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical and proton cancer therapy company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies.

Bitcoin Holdings

Total Bitcoin â‚¿ 10.5 BTC
% of 21M Supply 0.0%
Current Value $669,502
Cost Basis $1,196,832
ROI -44.06%
% of Company 0.8%
mNAV 120.14x
BTC/Share â‚¿ 0.00000096 BTC
Market Cap $83,089,552
Enterprise Value $83,684,970
Latest Purchase Sep 10, 2025
Avg. cost / BTC $113,984

Lixte Biotechnology Holdings Inc Stock Priced in BTC

0.000110 BTC

Lixte Biotechnology Holdings Inc Bitcoin Holdings Over Time

â‚¿ 10.5 BTC

Bitcoin Acquisitions History

Type BTC Change Holdings Transaction Value Date
Buy +0 BTC 0 BTC $0 —
Buy +0 BTC 0 BTC $0 —
Buy +0 BTC 0 BTC $0 —
Buy +0 BTC 0 BTC $0 —
Buy +0 BTC 0 BTC $0 —

Get instant access to full data

Request Access

Financial Highlights

Revenue (TTM) $0
Profit Margin 0%
Operating Margin 0%
ROE -101.95%
ROA -46.0%
EPS $-1.15
Book Value $0.902
Current Volume 183,247
Avg Volume (30d) 129,602
Volume vs Avg 1.41x

Lixte Biotechnology Holdings Inc Stock Price vs Bitcoin

$7.00 / $63,720

Company Overview

Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical and proton cancer therapy company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Boca Raton, Florida.

Sector Healthcare
Industry Biotechnology
Sub-Industry Biotechnology
Employees 3
Exchange NASDAQ
Fiscal Year End December
IPO Date September 2007

Stock Returns

Share Price $7.00
1W Return +16.86%
1M Return +55.9%
3M Return +162.17%
1Y Return +396.45%
1Y vs BTC +438.0%
52W High $7.50
% Down from 52W High -6.7%

Key Executives

Mr. Geordan G. Pursglove CEO, President & Chairman
Age: 38
Mr. Peter M. Stazzone Chief Financial Officer
Age: 74
Mr. Bastiaan van der Baan M.Sc. Chief Scientific Officer
Age: 54

Company Details

Address 433 Plaza Real, Boca Raton, FL, United States, 33432
Phone 631 830 7092
ISIN US5393192027
CIK 0001335105
Currency USD
Most Recent Quarter 2026-03-31

Growth Metrics

Earnings Growth (YoY) 0%
Revenue Growth (YoY) 0%

Balance Sheet (Q1 2026)

Total Assets $10,865,298
Total Liabilities $1,686,706
Total Equity $7,945,032
Cash & Equivalents $0
Total Debt $595,418
Current Assets $3,407,750
Current Liabilities $1,224,934
Long-term Debt $0

Additional Financials

Gross Profit $0
Revenue per Share $0
Diluted EPS (TTM) $-1.15
PEG Ratio 0
Outstanding Shares 10,889,000

EPS Estimates

Current Quarter $0
Current Year $0
Next Quarter $0
Next Year $0

Recent Insider Activity

Name Title Type Shares Price Value Date SEC
Der Baan Bastiaan Jeroen Van INSIDER Buy 10,000 $2.80 $28,000 Oct 03, 2023

Get instant access to full data

Request Access

Major Holders

Scotia Capital Inc
2.4341%
265,049 shares
Renaissance Technologies Corp
0.7995%
87,058 shares
Vanguard Group Inc
0.6442%
70,147 shares
Federation des caisses Desjardins du Quebec
0.5543%
60,358 shares
Geode Capital Management, LLC
0.5059%
55,087 shares
Citadel Advisors Llc
0.4862%
52,942 shares
Ethos Financial Group LLC
0.2133%
23,226 shares
XTX Topco Ltd
0.2015%
21,941 shares
State Street Corp
0.1495%
16,279 shares
Atlas Legacy Advisors, LLC
0.1184%
12,893 shares
Vanguard Institutional Extnd Mkt Idx Tr
0.4958%
53,988 shares
Fidelity Extended Market Index
0.245%
26,678 shares
Spartan Extended Market Index Pool F
0.0823%
8,962 shares
NT Ext Equity Mkt Index Fund - NL
0.0772%
8,406 shares
Fidelity Total Market Index
0.0732%
7,971 shares
Fidelity Series Total Market Index
0.0621%
6,762 shares
NT Ext Equity Mkt Idx Fd - DC - NL - T2
0.0605%
6,588 shares
Spartan Total Market Index Pool G
0.0366%
3,985 shares
Fidelity Nasdaq Composite Index
0.0067%
730 shares
Northern Trust Extended Eq Market Idx
0.0018%
196 shares

Frequently Asked Questions

Common questions about Lixte Biotechnology Holdings Inc's Bitcoin holdings

How much Bitcoin does Lixte Biotechnology Holdings Inc hold?

Lixte Biotechnology Holdings Inc currently holds 10.5 BTC, which represents 0.0% of the total Bitcoin supply (21 million). This makes them the 138th largest public Bitcoin holder.

What is the current value of Lixte Biotechnology Holdings Inc's Bitcoin holdings?

As of today, Lixte Biotechnology Holdings Inc's Bitcoin holdings are worth approximately $669,502. This represents 0.8% of the company's total market value.

What is Lixte Biotechnology Holdings Inc's average cost basis for Bitcoin?

Lixte Biotechnology Holdings Inc's average cost basis for their Bitcoin purchases is $1,196,832 per Bitcoin. Their current return on investment (ROI) is -44.06%.

When did Lixte Biotechnology Holdings Inc last buy Bitcoin?

Lixte Biotechnology Holdings Inc's most recent Bitcoin purchase was Sep 10, 2025. View purchase details

What type of company is Lixte Biotechnology Holdings Inc?

Lixte Biotechnology Holdings Inc is a public company in the Healthcare sector and Biotechnology industry with approximately 3 employees .

What is Lixte Biotechnology Holdings Inc's market capitalization?

Lixte Biotechnology Holdings Inc has a market capitalization of approximately $83,089,552 and annual revenue of $0 .

What is Lixte Biotechnology Holdings Inc's mNAV?

Lixte Biotechnology Holdings Inc's mNAV (Market-to-Net Asset Value) is 120.14x, comparing the company's market value to its Bitcoin holdings value. An mNAV of 1.0 means market value equals Bitcoin stash, while >1.0 indicates a premium for the company's Bitcoin strategy.

What is Lixte Biotechnology Holdings Inc's market cap and enterprise value?

Lixte Biotechnology Holdings Inc has a market capitalization of $83,089,552 and an enterprise value of $83,684,970. Enterprise value represents the total company value including debt and cash, providing a more complete valuation picture than market cap alone.

Chat

You are commenting as a guest. .

tanguma

Is anyone in here? should we start using this more?

Comment from Bitcoin Dashboard

jackson

Yo

Comment from Bitcoin Dashboard

tanguma

Hi

Comment from Research

5 June 2026

[REMOVED]

Greatly appreciated, thank you

30 October 2025

newhedge

Retirement calculator is fixed along with new initial BTC and annualized growth inputs

26 October 2025

newhedge

Data error, being fixed :)

23 October 2025

[REMOVED]

Anyone know why the retirement calculator has a predicted BTC price of ~$44k over a ten year period? I'm assuming I am reading it wrong

16 October 2025

spacegallagher

$80k???

28 February 2025

newhedge

$85k!

11 November 2024

spacegallagher

$80k!!!

10 November 2024

newhedge

New ATH!

6 November 2024

[REMOVED]

can i download historical bitcoin prices to excel?

13 September 2024

newhedge

New Onchain charts available on Onramp Terminal! Check the left sidenavbar.

25 July 2024

[REMOVED]

What is everyone's favorite resource to utilize through the terminal?

20 June 2024

philm23

To the Onramp team - any plans to add the net exchange reserve figures to the terminal?

10 March 2024

[REMOVED]

awesome terminal, very good job guys.

28 February 2024

[REMOVED]

Never mind I found it !

[REMOVED]

How do I edit my alerts ?

24 February 2024

[REMOVED]

I've been looking for a dataset of blockheight / price. Blockheight as the x variable. Does anyone know where I could find that?

7 February 2024

lifeonbtc

terminal chat - very cool/.